Clinical Trial

Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
Protocol Amendment History 1 change
notable Trial sites expanded: 20 -> 36 locations 2026-08-04
Trial Details
NCT Number NCT07287163
Lead Sponsor Praxis Precision Medicines
Conditions Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Enrollment 700 participants
Start Date 2025-10-27
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03